Use of 5HT-1F receptor antagonists for treating anxiety disorders
申请人:ELI LILLY AND COMPANY
公开号:EP0976747A3
公开(公告)日:2000-09-13
The present invention provides a method for the treatment of prevention of anxiety disorders which comprises administering to a mammal in need of such treatment a serotonin 5-HT1F receptor antagonist.
本发明提供了一种治疗预防焦虑症的方法,包括向需要此类治疗的哺乳动物施用一种5-HT1F受体拮抗剂。
5-HT1A and 5-HT1D alpha antagonists
申请人:ELI LILLY AND COMPANY
公开号:EP0881224A1
公开(公告)日:1998-12-02
A class of novel substituted-aryloxy-2-ol-3-(4-spiro-(alkanedioxy)isobenzofuranyl- and phthaloyl-piperidine)derivatives is disclosed useful as 5-HT1A and 5-HT1Dα antagonists.
[EN] 5-HT1A AND 5-HT1D alpha ANTAGONISTS<br/>[FR] ANTAGONISTES DE 5-HT1A ET 5-HT1D alpha
申请人:ELI LILLY AND COMPANY
公开号:WO1998053823A1
公开(公告)日:1998-12-03
(EN) A class of novel substituted-aryloxy-2-ol-3-(4-spiro-(alkanedioxy)isobenzofuranyl- and phthaloyl-piperidine) derivatives is disclosed useful as 5-HT1A and 5-HT1D$g(a) antagonists.(FR) Cette invention se rapporte à une classe de nouveaux dérivés aryloxy-2-ol-3-(4-spiro-(alcanedioxy)isobenzofuranyl- et phtaloyl-pipéridine) substitués qui s'avèrent utiles en tant qu'antagonistes de 5-HT1A ET 5-HT1D$g(a).